Warriors coach Steve Kerr once again called for change after a mass shooting at Brown University in Rhode Island left two dead and several more injured on early Sunday morning. Before Golden State’s ...

Another mass shooting, another impassioned plea for gun control from Steve Kerr. The Golden State Warriors coach spoke for about three minutes unprompted on Sunday night before their 136-131 loss ...

Over the past decades, engineers have introduced numerous technologies that rely on light and its underlying characteristics. These include photonic and quantum systems that could advance imaging, ...

At the beginning of this season, Jonathan Kuminga’s relationship with the Golden State Warriors appeared to be skyrocketing, but it turns out the trajectory was more like a boomerang. Kuminga did not ...

Warmer waters are fueling stronger, snowier storms—at least for now. Here’s how scientists think this phenomenon will evolve as the planet gets hotter. Steam is seen rising off a frozen Lake Michigan ...

Warriors head coach Steve Kerr has made clear that he is "very concerned" about how the NBA's pace of play and 82-game schedule are contributing to injuries around the league. The coach's comments ...

When he slams his fist in response to gun violence, when he wears Harvard’s colors in a stand against the Trump administration, when he attends public protests, like he did at last month’s “No Kings” ...

Bitcoin (BTC) has flashed its fourth death cross, a classic technical pattern that often precedes prolonged downside moves. The formation occurs when the 50-day moving average crosses below the ...

This film uses archival clips and documents to examine the way climate change evolved from nonpartisan topic to divisive issue. By Alissa Wilkinson When you purchase a ticket for an independently ...

Novartis is pulling back the curtain on late-stage Sjögren’s wins, revealing an edge for its investigational monoclonal antibody ianalumab over placebo in both studies. “Clearly, with Sjögren's having ...

Moderna is halting development of an mRNA vaccine for congenital cytomegalovirus after its candidate failed to protect women from the virus in a large phase 3 trial, the biotech announced in a ...